Atara Biotherapeutics Inc... (ATRA)
6.50
-0.38 (-5.52%)
At close: Mar 28, 2025, 3:59 PM
6.73
3.51%
Pre-market: Mar 31, 2025, 05:54 AM EDT
Atara Biotherapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -1.17 | -0.2 | -0.15 | -0.43 | -0.47 | -0.29 | -0.66 | -0.45 | -0.52 | -1.18 | -0.48 | -0.12 | -1.58 |
| PEG Ratio | 0.01 | -0.01 | 0.00 | 0.04 | 0.02 | -0.04 | -0.02 | -0.01 | -0.02 | 0.02 | 0.01 | -0.00 | n/a |
| PS Ratio | 0.77 | 6.34 | 5.26 | 72.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -1.02 | -0.55 | 2.64 | 5.28 | 3.14 | 2.91 | 4.49 | 3.04 | 1.61 | 2.14 | 1.29 | -0.93 | -52.39 |
| P/FCF Ratio | -1.45 | -0.28 | -1.22 | -6.39 | -7.84 | -3.5 | -7.06 | -5.02 | -6.47 | -18.04 | -8 | -1.72 | -78.03 |
| P/OCF Ratio | -1.45 | -0.28 | -1.24 | -6.69 | -8.03 | -3.59 | -8.47 | -6.18 | -6.8 | -18.18 | -8.02 | -1.72 | -78.88 |
| OCF/S Ratio | -0.53 | -22.51 | -4.25 | -10.84 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -0.31 | -0.58 | 0.57 | 0.09 | 0.03 | 0.05 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 0.40 | 0.65 | 3.72 | 3.64 | 6.31 | 7.43 | 8.04 | 6.23 | 26.93 | 33.43 | 38.92 | 33.99 | 3.26 |
| Current Ratio | 0.48 | 0.72 | 3.74 | 3.64 | 6.31 | 7.43 | 8.04 | 6.23 | 26.93 | 33.43 | 38.92 | 33.99 | 3.26 |
| Asset Turnover | 1.18 | 0.05 | 0.17 | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -18.08 | -52.22 | -141.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | 0.88 | 2.78 | -18.03 | -12.16 | -6.63 | -10.01 | -6.81 | -6.72 | -3.12 | -1.82 | -2.71 | 7.96 | 33.08 |
| Return on Assets (ROA) | -0.78 | -1.67 | -6.07 | -7.27 | -5.21 | -8.48 | -5.89 | -5.49 | -3 | -1.76 | -2.64 | -1.69 | -28.74 |
| Return on Capital (ROIC) | 3.28 | -11.86 | -0.94 | -0.94 | -0.61 | -0.97 | -0.67 | -0.64 | -0.32 | -0.19 | -0.27 | -0.17 | -1.08 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 83.71% | -3.65% | 77.08% | 44.05% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -66.23% | -3.22K% | -3.59K% | -16.72K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -66.24% | -3.22K% | -359.1% | -1.67K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -64.71% | -3.22K% | -441.25% | -1.67K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -53.48% | -2.27K% | -431.98% | -1.14K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -58.75% | -3.1K% | -336.18% | -1.63K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |